News Results
There are 619,576 News Results
Jun 10, 2025
-The Study Met Primary and All Secondary Efficacy Endpoints-
Jun 10, 2025
CUSIP 35905B AC1 (144A) / C35898 AB8 (Reg S)
Jun 11, 2025
CHICAGO, June 11, 2025 /PRNewswire/ --
Jun 11, 2025
CHICAGO, June 11, 2025 /PRNewswire/ --
Jun 11, 2025
CHICAGO, June 11, 2025 /PRNewswire/ --
Jun 11, 2025
CHICAGO, June 11, 2025 /PRNewswire/ --
Jun 11, 2025
-- MAVYRET(®) (glecaprevir/pibrentasvir) is the first and only oral eight-week pangenotypic treatment option approved for people with acute or chronic hepatitis C virus (HCV)* -- With this approval, providers can...
Jun 11, 2025
BRIDGEWATER, N.J., June 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing...
Jun 11, 2025
The multiple sclerosis market is growing due to rising prevalence, earlier diagnosis, and wider access to care. Demand is fueled by advancements in DMTs and emerging BTK inhibitors, which offer...
Jun 12, 2025
Key announcements: